Markets
News
Analysis
Tools
Learn
Features
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Sign Up
Markets
/
Stocks
/
nasdaq-krro
/
Korro Bio Inc
KRRO
15.160
USD
+1.310
+9.46%
Market hours (ET)
Quotes delayed by 15 min
USD
0.000
Pre-market (ET)
142.34M
Market Cap
Loss
P/E TTM
Korro Bio Inc
15.160
+1.310
+9.46%
Overview
Company
Financials
Statements
Income Statement
Balance Sheet
Cash Flow Statement
Overview
Company
Financials
Statements
Income Statement
Balance Sheet
Cash Flow Statement
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
Operating cash flows (indirect method)
Cash flow from continuing operating activities
-11.70%
-24.45M
--
-7.50M
--
-16.09M
--
-14.59M
--
-21.89M
Net income from continuing operations
-19.58%
-23.39M
--
-21.20M
--
-21.00M
--
-21.83M
--
-19.56M
Operating gains losses
68.73%
1.23M
--
1.25M
--
865.00K
--
721.00K
--
726.00K
Other non-cash items
-115.13%
-182.00K
--
-440.00K
--
-168.00K
--
939.00K
--
1.20M
Change in working capital
24.55%
-3.87M
--
11.18M
--
2.94M
--
4.61M
--
-5.13M
-Change in receivables
--
-228.00K
--
-1.70M
--
--
--
--
--
--
-Change in prepaid expenses
-112.76%
-617.00K
--
167.00K
--
499.00K
--
-1.10M
--
-290.00K
-Change in other current assets
-572.09%
-406.00K
--
110.00K
--
58.00K
--
86.00K
--
86.00K
-Change in other current liabilities
--
-626.00K
--
9.43M
--
--
--
--
--
--
Cash from non-recurring investing activities
Cash from operating activities
-11.70%
-24.45M
--
-7.50M
--
-16.09M
--
-14.59M
--
-21.89M
Investing cash flow
Net cash from continuing investing activities
-97.88%
119.00K
--
1.45M
--
4.88M
--
5.96M
--
5.61M
Capital expenditures
-97.88%
119.00K
--
1.45M
--
4.88M
--
5.96M
--
5.61M
Net cash flow from disposal of fixed assets
-97.88%
119.00K
--
1.45M
--
4.88M
--
5.96M
--
5.61M
Net cash flow from investment products
--
32.90M
--
-1.31M
--
-7.70M
--
-96.43M
--
0.00
Cash from non-current investing activities
Net cash flow from investing activities
684.23%
32.78M
--
-2.77M
--
-12.58M
--
-102.39M
--
-5.61M
Financing cash flow
Cash flow from continuous financing activities
23.74%
172.00K
--
932.00K
--
728.00K
--
67.56M
--
139.00K
Net cash flow from common stock issuance/repurchase
--
--
--
1.00K
--
0.00
--
67.38M
--
--
Net cash flow from preferred stock issuance/repurchase
--
--
--
--
--
0.00
--
0.00
--
0.00
Proceeds from stock option exercised by employees
23.74%
172.00K
--
931.00K
--
728.00K
--
172.00K
--
139.00K
Net cash flow from other financing activities
--
--
--
0.00
--
0.00
--
0.00
--
0.00
Net cash from non-recurrent financing activities
Net cash from financing activities
23.74%
172.00K
--
932.00K
--
728.00K
--
67.56M
--
139.00K
Net cash flow
Beginning cash balance
-65.89%
59.05M
--
68.38M
--
96.32M
--
145.76M
--
173.12M
Current period cash flow changes
131.07%
8.50M
--
-9.33M
--
-27.94M
--
-49.43M
--
-27.36M
Effect of exchange rate changes
--
--
--
-6.00K
--
2.00K
--
--
--
--
Ending cash balance
-53.66%
67.55M
--
59.05M
--
68.38M
--
96.33M
--
145.76M
Free cash flow
10.66%
-24.57M
--
-8.95M
--
-20.97M
--
-20.55M
--
-27.50M
Currency unit
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
KeyAI
Please log in to use KeyAI
Log in
Sign Up